[Clinical study of mesoridazine (TPS-23) with psychotic patients].
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D001007:Anxiety / Q000188:drug therapy; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects
D014149:Tranquilizing Agents
Essai clinique de la mesoridazine (TPS-23) chez des patients psychotiques.